Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Other
    • ASN Publications
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • ASN Publications
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
BRIEF COMMUNICATIONS
You have accessRestricted Access

Serum Cystatin C as a Determinant of Fasting Total Homocysteine Levels in Renal Transplant Recipients with a Normal Serum Creatinine

ANDREW G. BOSTOM, REGINALD Y. GOHH, LINDA BAUSSERMAN, DAVID HAKAS, PAUL F. JACQUES, JACOB SELHUB, LANCE DWORKIN and IRWIN H. ROSENBERG
JASN January 1999, 10 (1) 164-166; DOI: https://doi.org/10.1681/ASN.V101164
ANDREW G. BOSTOM
*
†
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
REGINALD Y. GOHH
‡
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LINDA BAUSSERMAN
§
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DAVID HAKAS
‡
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PAUL F. JACQUES
†
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JACOB SELHUB
†
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LANCE DWORKIN
‡
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
IRWIN H. ROSENBERG
†
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Abstract

Abstract. Serum creatinine, a surrogate for both renal function and homocysteine generation, is an important determinant of fasting plasma total homocysteine levels in stable renal transplant recipients. In this study, it is hypothesized that among stable renal transplant recipients with normal creatinine levels (i.e., ≤ 1.5 mg/dl), serum cystatin C, a more sensitive indicator of GFR, would better predict fasting total homocysteine levels compared with serum creatinine. Fasting plasma total homocysteine, folate, vitamin B12, and pyridoxal 5′-phosphate levels, along with serum cystatin C, creatinine, and albumin levels, were determined in 28 consecutive renal transplant recipients (mean age 47 ± 14 yr; 60.7% men) with stable allograft function, whose serum creatinine was ≤1.5 mg/dl. General linear modeling with analysis of covariance revealed that serum cystatin C was independently predictive (partial R = 0.494; P = 0.023) of fasting total homocysteine levels after adjustment for age, gender, vitamin status, albumin, and creatinine levels. In contrast, creatinine levels were not predictive of fasting total homocysteine levels in this model (P = 0.110) or an identical model that excluded cystatin C (P = 0.131). Serum cystatin C levels may reflect subtle decreases in renal function that independently predict fasting total homocysteine levels among stable renal transplant recipients with a normal serum creatinine.

Recently, we provided controlled evidence that clinically stable renal transplant recipients have an excess prevalence of mild hyperhomocysteinemia (1), which may contribute to their disproportionately high rates of arteriosclerotic outcomes (2). Creatinine, a surrogate for both renal function (i.e., GFR [3]) and stoichiometric generation of homocysteine coupled to creatine-creatinine synthesis (4), is an important determinant of total homocysteine (tHcy) levels in both renal transplant recipients (1,5) and the general population (6). It has been demonstrated, however, that the specific relationship between serum creatinine and GFR among renal transplant recipients is highly variable, being influenced by altered muscle mass and catabolic rate, as well as changes in tubular secretion of creatinine (7). Cystatin C is a nonglycosylated 13-kD basic protein produced at a stable rate by all investigated nucleated cells, whose serum concentration is primarily determined by the GFR (8). Consistent reports (9,10,11,12) now clearly indicate that serum cystatin C is superior to serum creatinine as an index of GFR in adults, including renal transplant recipients (12), particularly for the detection of early decreases in GFR (11,12). Using iohexol clearance data, it has previously been shown (13) that there is a strong, independent (inverse) association between GFR, but not serum creatinine, and fasting tHcy levels, which encompasses GFR that are only very mildly reduced (i.e., 50 to 75 ml · min-1). Accordingly, we hypothesized that among renal transplant recipients with normal creatinine levels (≤1.5 mg/dl), serum cystatin C, as a more sensitive indicator of GFR, would better predict fasting tHcy levels compared to serum creatinine. To test this hypothesis, fasting plasma tHcy, serum creatinine, and serum cystatin C were assessed, along with the other established determinants of tHcy levels (age [14], gender [14], B-vitamin status [14], and albumin [15]), in consecutive renal transplant recipients with clinically stable allograft function whose serum creatinine was ≤1.5 mg/dl.

Materials and Methods

The institutional review board at Rhode Island Hospital (Providence, RI) approved the study protocol, and all participants provided written informed consent. Study participants were 28 stable renal transplant patients (i.e., they were at least 6 mo posttransplantation with no clinical evidence of renal graft rejection), whose serum creatinine was ≤1.5 mg/dl. All participants lived in the Providence metropolitan area and were examined between October 1997 and May 1998. Information regarding prior vitamin supplement use was obtained by standardized interview, and subjects were either nonusers of any supplements containing folic acid, or had abstained from using such supplements for at least 6 wk by the time of their examination.

Overnight (10 to 14 h) fasting blood samples were collected from each participant. tHcy levels were determined by HPLC with fluorescence detection, and plasma pyridoxal 5′-phosphate levels were measured by radioenzymatic (tyrosine decarboxylase) assay, as reported earlier (1). Plasma folate and vitamin B12 levels were measured by radioassay (BioRad Quantaphase II, Hercules, CA). Serum creatinine (Jaffe method) and albumin (bromcresol method) levels were determined using standard techniques adapted for automated clinical chemistry laboratory analyzers. Serum cystatin C levels were determined by particle-enhanced immunoturbidimetry (11).

Statistical Analyses

All skewed continuous variables were (natural log) transformed to better approximate a normal distribution, and unadjusted correlations between continuous variables were assessed in a Pearson correlation matrix. General linear modeling with analysis of covariance was then performed to determine the independent association between potential predictor covariables and fasting tHcy levels. Immunosuppressive drug regimen data were not included in these models because there is no evidence that the agents currently utilized independently influence tHcy levels, after appropriate adjustment for renal function indices (1,5), or other established determinants of tHcy levels (5). Reported P values were based on two-tailed calculations, and all statistical analyses were performed using SYSTAT (version 7.0.1) software.

Results

Key subject characteristics expressed as means, geometric means, percentages, and complete ranges are depicted in Table 1. There was a trend for unadjusted geometric mean fasting tHcy levels to be greater in the men (n = 17) than in the women (n = 11) (12.1 versus 10.3 μM; P = 0.076). Analysis of covariance, adjusting for age, vitamin status, creatinine, and cystatin C, confirmed the independence of this gender difference (men = 12.4 μM, women = 9.8 μM, P = 0.017). Unadjusted Pearson correlations between the continuous variables examined are illustrated in Table 2. Creatinine was modestly correlated with tHcy (r = 0.214), as well as most of the usual determinants of tHcy levels, including pyridoxal 5′-phosphate, folate, age, and albumin (r ≥ 0.220). Although also correlated with tHcy (r = 0.306), cystatin C, in contrast to creatinine, was not correlated with either age, albumin, or B12 (r ≤ 0.044), and only weakly correlated with folate (r = 0.177) and pyridoxal 5′-phosphate (r = 0.150). General linear modeling with analysis of covariance (i.e., stepwise and “forced” forward or backward), revealed that only cystatin C (partial R = 0.494; P = 0.023) and gender (partial R = 0.486; P = 0.026) were independent predictors of fasting tHcy levels, after simultaneous adjustment for age, creatinine, albumin, folate, pyridoxal 5′-phosphate, and B12. Creatinine levels were not independently predictive of fasting tHcy levels in any of these models (partial R = 0.359; P = 0.110), or identical models that differed only by the exclusion of cystatin C levels (partial R = 0.332; P = 0.131).

View this table:
  • View inline
  • View popup
Table 1.

Subject characteristicsa

View this table:
  • View inline
  • View popup
Table 2.

Pearson correlation matrix of natural log-transformed data

Discussion

Previous reports (9,10,11,12), including a recent study of renal transplant recipients (12), have revealed that cystatin C is a more sensitive marker of mildly impaired GFR compared with creatinine, and that GFR itself, even into the normative range, is a powerful, independent predictor of fasting tHcy levels (13). Expanding on these combined observations, we report the first analysis indicatint that serum cystatin C levels may independently predict fasting tHcy levels among stable renal transplant recipients with normal serum creatinine levels. Clearly, larger studies will be required to confirm the external validity of the present findings.

At present, it is unknown whether the persistent mild hyperhomocysteinemia characteristic of chronic renal insufficiency and end-stage renal disease (16) results from the loss of intrarenal homocysteine metabolism (17) or uremia-induced extrarenal defects in homocysteine metabolism (18). The findings reported here from nonuremic subjects might suggest that intrarenal homocysteine metabolism is a major determinant of homocysteine levels. However, these data cannot rule out the possibility that subtle extrarenal defects in homocysteine metabolism that may accompany even such mild reductions in renal function could account for the resulting increases in tHcy levels.

Studies using serum cystatin C determinations to assess subclinical deterioration in renal function and homocysteinemia within other patient populations, e.g., patients with arteriosclerotic cardiovascular disease, may be warranted. An initial analysis (19) using cystatin C as a surrogate for GFR in healthy subjects has already indicated that the well characterized increase in plasma tHcy levels with advancing age may be due in part to an agerelated decline in renal function. Finally, given that clinical renal disease renders individuals refractory to the effect of low-dose folic acid supplementation on fasting tHcy levels (16), cystatin C data might also be useful in evaluating the influence of subclinical renal impairment on tHcy-lowering treatment responsiveness.

In summary, serum cystatin C levels may reflect subtle decreases in renal function that independently predict fasting tHcy levels among stable renal transplant recipients with normal serum creatinine levels.

Acknowledgments

Acknowledgments

This work was supported in part by a grant from Roche Vitamin Division. We thank Susan Ritter, Evelyn Tolbert, Marie Nadeau, and Bonnie Soupa, for their excellent technical assistance.

Footnotes

  • American Society of Nephrology

  • © 1999 American Society of Nephrology

References

  1. ↵
    Bostom AG, Gohh RY, Tsai MY, Hopkins-Garcia BJ, Nadeau MR, Bianchi LA: Excess prevalence of fasting and post-methionine loading hyperhomocysteinemia in stable renal transplant recipients. Arterioscler Thromb Vasc Biol17 : 1894-1900,1997
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Kasiske BL, Guijarro C, Massy Z, Wiederkehr MR, Ma Z: Cardiovascular disease after renal transplantation. J Am Soc Nephrol 7:158 -165, 1996
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31 -41, 1976
    OpenUrlCrossRefPubMed
  4. ↵
    Mudd SH, Poole JR: Labile methyl balances for normal humans on various dietary regimens. Metabolism24 : 721-735,1975
    OpenUrlCrossRefPubMed
  5. ↵
    Ducloux D, Fournier V, Rebibou JM, Bresson-Vautrin C, Gibey R, Chalopin JM: Hyperhomocysteinemia in renal transplant recipients with and without cyclosporine. Clin Nephrol19 : 232-235,1998
    OpenUrl
  6. ↵
    Brattstrom L, Lindgren A, Israelsson B, Anderson A, Hultberg B: Homocysteine and cysteine: Determinants of plasma levels in middle-aged to elderly subjects. J Intern Med236 : 633-641,1994
    OpenUrlCrossRefPubMed
  7. ↵
    Nankivell BJ, Gruenewald SM, Allen RD, Chapman JR: Predicting glomerular filtration rate after kidney transplantation. Transplantation 59:1683 -1689, 1995
    OpenUrlCrossRefPubMed
  8. ↵
    Simonsen O, Grubb A, Thysell H: The blood serum concentration of cystatin C (γ-trace) as a measure of the glomerular filtration rate. Scand J Clin Lab Invest 45:97 -101, 1985
    OpenUrlCrossRefPubMed
  9. ↵
    Pergande M, Jung K: Sandwich enzyme immunoassay for cystatin C in serum with commercially available antibodies. Clin Chem 39:1885 -1890, 1993
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Khyse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindstrom V: Serum cystatin C, determined by a rapid automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem40 : 1921-1926,1994
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO: Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinine. Kidney Int47 : 312-318,1995
    OpenUrlCrossRefPubMed
  12. ↵
    Plebani M, Dall'Amico R, Mussap M, Montini G, Ruzzante N, Marsilio R, Giordano G: Is serum cystatin C a sensitive marker of glomerular filtration rate (GFR)? A preliminary study on renal transplant patients. Ren Fail 20: 303-309,1998
    OpenUrlCrossRefPubMed
  13. ↵
    Arnadottir M, Hultberg B, Nilsson-Ehle P, Thysell H: The effect of reduced glomerular filtration rate on plasma total homocysteine concentrations. Scand J Clin Lab Invest56 : 41-46,1996
    OpenUrlPubMed
  14. ↵
    Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH: Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270:2693 -2698, 1993
    OpenUrlCrossRefPubMed
  15. ↵
    Lussier-Cacan S, Xhignesse M, Piolot A, Selhub J, Davignon J, Genest J Jr: Plasma total homocysteine in healthy subjects: Sex-specific relation with biological traits. Am J Clin Nutr64 : 587-593,1996
    OpenUrlAbstract/FREE Full Text
  16. ↵
    Bostom AG, Lathrop L: Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 52:10 -20, 1997
    OpenUrlCrossRefPubMed
  17. ↵
    Bostom AG, Brosnan JT, Hall B, Nadeau MR, Selhub J: Net uptake of plasma homocysteine by the rat kidney in vivo. Atherosclerosis 116:59 -62, 1995
    OpenUrlCrossRefPubMed
  18. ↵
    van Guldener C, Donker AJ, Jakobs C, Teerlink T, de Meer K: No net renal extraction of homocysteine in fasting humans. Kidney Int 54: 166-169,1998
    OpenUrlCrossRefPubMed
  19. ↵
    Norlund L, Grubb A, Fex G, Leksell H, Nilsson JE, Schenk H: The increase of plasma homocysteine concentrations with age is partly due to the deterioration of renal function as determined by plasma cystatin C. Clin Chem Lab Med 36:175 -178, 1998
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 10 (1)
Journal of the American Society of Nephrology
Vol. 10, Issue 1
1 Jan 1999
  • Table of Contents
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
Serum Cystatin C as a Determinant of Fasting Total Homocysteine Levels in Renal Transplant Recipients with a Normal Serum Creatinine
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Serum Cystatin C as a Determinant of Fasting Total Homocysteine Levels in Renal Transplant Recipients with a Normal Serum Creatinine
ANDREW G. BOSTOM, REGINALD Y. GOHH, LINDA BAUSSERMAN, DAVID HAKAS, PAUL F. JACQUES, JACOB SELHUB, LANCE DWORKIN, IRWIN H. ROSENBERG
JASN Jan 1999, 10 (1) 164-166; DOI: 10.1681/ASN.V101164

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Serum Cystatin C as a Determinant of Fasting Total Homocysteine Levels in Renal Transplant Recipients with a Normal Serum Creatinine
ANDREW G. BOSTOM, REGINALD Y. GOHH, LINDA BAUSSERMAN, DAVID HAKAS, PAUL F. JACQUES, JACOB SELHUB, LANCE DWORKIN, IRWIN H. ROSENBERG
JASN Jan 1999, 10 (1) 164-166; DOI: 10.1681/ASN.V101164
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

  • Serum Response Factor Is Essential for Maintenance of Podocyte Structure and Function
  • Phospholipase A2 Receptor 1 Epitope Spreading at Baseline Predicts Reduced Likelihood of Remission of Membranous Nephropathy
  • TRPC5 Does Not Cause or Aggravate Glomerular Disease
Show more BRIEF COMMUNICATIONS

Cited By...

  • Increased Serum Concentrations of Homocysteine and Lipoprotein (a) in Familial Mediterranean Fever
  • The Homocysteine Paradox
  • Thermolabile methylenetetrahydrofolate reductase, homocysteine, and cardiovascular disease risk: the European Concerted Action Project
  • The Relationship Among Homocysteine, Creatinine Clearance, and Albuminuria in Patients With Type 2 Diabetes
  • The Kidney and Homocysteine Metabolism
  • Cystatin C Is an Independent Predictor of Fasting and Post-Methionine Load Total Homocysteine Concentrations among Stable Renal Transplant Recipients
  • Homocysteine and cardiovascular disease: cause or effect?
  • Plasma Homocysteine, Aortic Stiffness, and Renal Function in Hypertensive Patients
  • Cystatin C as a Determinant of Fasting Plasma Total Homocysteine Levels in Coronary Artery Disease Patients With Normal Serum Creatinine
  • Hyperhomocysteinemia in Chronic Renal Disease
  • Google Scholar

Similar Articles

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe to ASN Journals
  • Wolters Kluwer Partnership

© 2022 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire